Journal of nuclear medicine : official publication, Society of Nuclear MedicineHumansMalePositron Emission Tomography Computed TomographyProstatic NeoplasmsAged
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial.
Philipp Krausewitz, Markus Essler, Florian C Gaertner, Ulrike Attenberger, Julian A Luetkens, Glen Kristiansen, Marit Bernhardt, Carsten-Henning Ohlmann, Michael Anspach, Matthias Schmid, Robert Nemeth, Jennifer Schmitz, Stefan Hauser, Joerg Ellinger, Manuel Ritter
Published: 202610.2967/jnumed.125.271344
Abstract
68Ga-PSMA-11 PET/CT (PSMA PET/CT) is used for staging advanced prostate cancer (PCa); however, its role in initial cancer detection and guiding localized treatment remains uncertain. The primary objective of this study was to assess the impact of upf…
Preview only. Read the full abstract at the source